FR2013170A1 - - Google Patents

Info

Publication number
FR2013170A1
FR2013170A1 FR6923466A FR6923466A FR2013170A1 FR 2013170 A1 FR2013170 A1 FR 2013170A1 FR 6923466 A FR6923466 A FR 6923466A FR 6923466 A FR6923466 A FR 6923466A FR 2013170 A1 FR2013170 A1 FR 2013170A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR6923466A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOGERAS
Original Assignee
SOGERAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOGERAS filed Critical SOGERAS
Publication of FR2013170A1 publication Critical patent/FR2013170A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6923466A 1968-07-18 1969-07-10 Pending FR2013170A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3438268 1968-07-18

Publications (1)

Publication Number Publication Date
FR2013170A1 true FR2013170A1 (xx) 1970-03-27

Family

ID=10364956

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6923466A Pending FR2013170A1 (xx) 1968-07-18 1969-07-10

Country Status (8)

Country Link
BE (1) BE735129A (xx)
CH (1) CH502386A (xx)
DE (1) DE1936723C2 (xx)
ES (1) ES369337A1 (xx)
FR (1) FR2013170A1 (xx)
GB (1) GB1227830A (xx)
NL (1) NL149808B (xx)
OA (1) OA03630A (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2086478A1 (xx) * 1970-04-30 1971-12-31 Sogeras
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
EP0676206B1 (en) * 1993-09-20 2000-01-05 Ajinomoto Co., Inc. Antimalarial
WO1995034571A2 (en) * 1994-06-10 1995-12-21 Dumex Alpharma A/S Drug salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1143204B (de) * 1958-08-05 1963-02-07 Mundipharma Ag Verfahren zur Herstellung von Chinidingalacturonat und Chinidinpolygalacturonat
DE1218457B (de) * 1961-10-10 1966-06-08 Mundipharma Ag Verfahren zur Herstellung von Dihydrochinidingalakturonat und Dihydrochinidinpolygalakturonat

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2086478A1 (xx) * 1970-04-30 1971-12-31 Sogeras
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders

Also Published As

Publication number Publication date
DE1936723A1 (de) 1970-05-14
CH502386A (fr) 1971-01-31
OA03630A (fr) 1971-12-24
DE1936723C2 (de) 1983-12-22
NL149808B (nl) 1976-06-15
BE735129A (xx) 1969-12-01
GB1227830A (xx) 1971-04-07
NL6910987A (xx) 1970-01-20
ES369337A1 (es) 1971-06-01

Similar Documents

Publication Publication Date Title
AU1946070A (xx)
AU428130B2 (xx)
AU2374870A (xx)
AU5184069A (xx)
AU6168869A (xx)
AU6171569A (xx)
AU429879B2 (xx)
AU416157B2 (xx)
AU2581067A (xx)
AU4811568A (xx)
AU421558B1 (xx)
AU4744468A (xx)
AU3789668A (xx)
AU2580267A (xx)
AU479393A (xx)
BE708888A (xx)
AU4503667A (xx)
AU4558658A (xx)
AU463027A (xx)
AU4270368A (xx)
BE728386A (xx)
AU479894A (xx)
AU4224469A (xx)
BE728327A (xx)
AU3083868A (xx)

Legal Events

Date Code Title Description
CL Concession to grant licences
CD Change of name or company name
CD Change of name or company name
TP Transmission of property